UBS Group AG - ACURX PHARMACEUTICALS INC ownership

ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 13 filers reported holding ACURX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$10,048
-7.7%
2,904
+6.1%
0.00%
Q4 2022$10,889
-9.3%
2,736
-33.1%
0.00%
Q3 2022$12,000
+200.0%
4,089
+292.8%
0.00%
Q2 2022$4,0001,0410.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Draper Asset Management, LLC 266,025$873,0000.72%
Patriot Financial Group Insurance Agency, LLC 9,750$32,0000.01%
Semmax Financial Advisors Inc. 1,263$4,0000.00%
TD Waterhouse Canada Inc. 30,000$102,3000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,941$35,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 10,100$33,0000.00%
BlackRock Inc. 16,699$55,0000.00%
Tower Research Capital LLC (TRC) 3,319$11,0000.00%
WELLS FARGO & COMPANY/MN 16$00.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders